Voglaz M 0.3 Tablet SR
Marketer
Hicxica Formulations Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Voglaz M 0.3 Tablet SR
Diabeva SR 0.3mg tablets are antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. They help manage blood glucose. Diabeva SR 0.3mg tablets should be taken with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are typically transient and self-limiting. Persistent or concerning side effects warrant medical attention; your doctor can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Voglaz M 0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglaz M 0.3 Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Voglaz M 0.3 Tablet SR with a meal.
Common Side effects of Voglaz M 0.3 Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Voglaz M 0.3 Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Voglaz M 0.3 Tablet SR with a meal.
How Voglaz M 0.3 Tablet SR works:
Voglaz M 0.3 Extended-Release tablet contains a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Voglaz M 0.3 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Voglaz M 0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglaz M 0.3mg tablets may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential drug transfer via breast milk, potentially harming the nursing child.
DrivingSAFE
Driving ability is typically unaffected by Voglaz M 0.3 Tablet SR. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if taken concurrently with other diabetes medications, including sulfonylureas, insulin, and repaglinide.
KidneyCAUTION
Patients with kidney impairment should use Voglaz M 0.3 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Regular kidney function monitoring is recommended during treatment; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Voglaz M 0.3 Tablet SR use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Voglaz M 0.3 Tablet SR :
Should you forget to take a Voglaz M 0.3 Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglaz M 0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |




